Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Cairo University
Cairo, Egypt
NCT Number: NCT07532798
This study is about a treatment for a jaw condition called temporomandibular joint (TMJ) subluxation. In this condition, the jaw can move too far forward during mouth opening, which may cause repeated jaw locking and problems with normal function.
The treatment being studied is platelet-rich plasma (PRP) injections. PRP is made from a person's own blood and may help improve joint stability and reduce symptoms.
In this study, 40 adults with TMJ subluxation were randomly assigned to receive PRP with either a lower or higher platelet concentration. Each participant received 2 injections, given 2 weeks apart.
The study measured jaw pain, how often locking happened, mouth opening, and joint clicking before treatment, after 6 months, and after 5 years.
The goal of this study is to find out whether the amount of platelets in PRP changes how well this treatment works.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Cairo, Egypt
This prospective, double-blinded, parallel-group randomized clinical trial was conducted to evaluate whether platelet concentration influences the clinical efficacy of platelet-rich plasma (PRP) prolotherapy in the management of temporomandibular joint (TMJ) subluxation. TMJ subluxation is characterized by recurrent episodes of excessive anterior translation of the mandibular condyle beyond the articular eminence, often resulting in transient jaw locking and functional impairment.
A total of 40 adult patients (≥18 years) diagnosed with TMJ subluxation according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD), supported by imaging evidence, were enrolled and randomly allocated in a 1:1 ratio into two groups: low-concentration PRP (L-PRP) and high-concentration PRP (H-PRP). PRP was prepared using standardized centrifugation protocols (1,500 rpm for L-PRP and 3,200 rpm for H-PRP). All participants received two intra-articular and pericapsular injections separated by a 2-week interval.
The primary outcomes were TMJ pain on function, assessed using a visual analog scale (VAS), and frequency of joint locking (episodes/day). Secondary outcomes included maximal mouth opening (MMO, mm) and presence of joint clicking. Outcomes were assessed at baseline, 6 months, and 5 years following treatment.
The study aimed to determine whether variations in platelet concentration affect clinical outcomes of PRP prolotherapy and to provide evidence for optimizing PRP preparation protocols in the management of TMJ subluxation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
patients aged ≥ 18 years -
Exclusion criteria
patients aged < 18 years
-
Intra-articular and pericapsular injection of platelet-rich plasma prepared with Low platelet concentration..
Intra-articular and pericapsular injection of platelet-rich plasma prepared with high platelet concentration.
Time frame: Baseline, 6 months, and 5 years
Pain during jaw function measured using a visual analog scale (VAS) from 0 to 10, where 0 indicates no pain and 10 indicates worst pain.
Time frame: Baseline, 6 months, and 5 years
Frequency of locking, expressed as number of episodes per day
Time frame: Baseline, 6 months, and 5 years
MMO measured as the distance in mm between the incisal edges of the upper and lower central incisors using a ruler.
Time frame: Baseline, 6 months, and 5 years
TMJ clicking, recorded as present or absent based on periauricular palpation during mandibular movement.
IBB University
Other
Effect of Platelet Concentration in Platelet-Rich Plasma on Prolotherapy Outcomes in Temporomandibular Joint Subluxation: A Double-Blinded Randomized Clinical Trial
Acronym: PRPTMJ
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07392671
Craniomandibular Disorders, Jaw Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07397013
Craniomandibular Disorders, Internal Derangement of the Tempromandibular Joint
Al Mansurah, Egypt
View Trial DetailsNCT07329413
Anterior Disc Displacement, Craniomandibular Disorders
Rize, Rize Province, Turkey (Türkiye)
View Trial DetailsNCT07045441
Behavior, Behavioral Counseling
Al Mansurah, Dakahlia Governorate, Egypt
View Trial Details